US$ 25.17
foxo4 dri senolytic human trial 2024 2025 Development of a novel by precise disruption of FOXO4-p53 complex Senescent cells as a target
Description
Walters AS, Silvestri R, Zucconi M, Chandrashekariah R, Konofal E

For example, combining Epitalon for telomere maintenance with MOTS-c for mitochondrial function addresses two distinct aging mechanisms

PMID: 28653751

Ready to invest in decades of stronger living
Indian Point Safe Energy Coalition

Improper dosing may reduce effectiveness or increase the risk of adverse effects
